Home - Avidity Biosciences
Description: Have you been diagnosed with FSHD1 or FSHD2? Learn more about this clinical research study for adults with Facioscapulohumeral Muscular Dystrophy
clinical trial (179) clinical study (46) muscular dystrophy (41) fshd (6) muscle weakness (4) facioscapulohumeral muscular dystrophy (1) fshd treatment (1)
The FORTITUDE™ study will evaluate the safety, tolerability, and effectiveness of a new investigational medication in eligible individuals with FSHD.
Participants will be enrolled in the FORTITUDE™ study for approximately 13.5 months, including screening. An Open-Label Extension study is also planned.
This study will take place at multiple clinical sites in several countries. Click here to view our map and find a participating site location near you.
Home - Avidity Biosciences